HCG vs SHALBY: Stock Comparison
HEALTHCARE GLOB. ENT. is the larger company by market capitalisation. HEALTHCARE GLOB. ENT. shows faster revenue growth, while SHALBY shows a lower P/E, a higher ROE and lower leverage. These are relative readings on individual metrics — weigh valuation against growth, margins, leverage and capital efficiency rather than treating any single number as decisive.
Metric snapshot
HCG leads 3; SHALBY leads 9 of 13
Interactive comparison
Compare the numbers that shape the decision
Every row uses its own scale. Switch lenses to compare like with like.
Valuation lens
What price are you paying?
✓ marks the usual favourable reading; it is not a recommendation.
Key Differences
Each difference is a single, relative reading — StockeZee does not name an overall winner.
Profile
| Metric | HCG | SHALBY |
|---|---|---|
| Sector | Healthcare | Healthcare |
| Industry | Hospital | Hospital |
Price
| Metric | HCG | SHALBY |
|---|---|---|
| Live Price | ₹693.9 | ₹144.78 |
| Day Change | -1% | -0.81% |
| Volume | 44,421 | 1.13 L |
| 52-Week High | ₹804.65 | ₹274.7 |
| 52-Week Low | ₹513.3 | ₹125.82 |
| Distance from 52W High | -13.76% | -47.3% |
Valuation
| Metric | HCG | SHALBY |
|---|---|---|
| Market Cap | ₹10,356 Cr | ₹1,557 Cr |
| P/E Ratio | 453.37x | 40.03x |
| P/B Ratio | 7.78x | 1.57x |
| EPS | ₹0.92 | ₹1 |
| Book Value | ₹94.45 | ₹93.11 |
| Dividend Yield | 0% | 0% |
Growth
| Metric | HCG | SHALBY |
|---|---|---|
| Revenue Growth (TTM YoY) | 11.5% | 8.5% |
| EPS Growth (TTM YoY) | -71.2% | 0% |
| Qtr Sales Growth | 84.54% | 30.51% |
| Qtr Profit Growth | 194.98% | -58.13% |
Profitability & Leverage
| Metric | HCG | SHALBY |
|---|---|---|
| ROE | 0.91% | 9.06% |
| ROCE | 5.66% | 9.26% |
| Net Margin | 0.54% | 3.28% |
| Operating Margin | 7.04% | 14.33% |
| Debt to Equity | 0.35x | 0.1x |
Shareholding
As of Jun 2026 • change vs previous quarter| Metric | HCG | SHALBY |
|---|---|---|
| Promoter Holding | 9.94% | 74.33% |
| FII Holding | 2.74%▼ 0.01 pp | 4.46%▲ 0.1 pp |
| DII Holding | 19.2%▲ 0.29 pp | 0.3%▲ 0.05 pp |
| Public Holding | 13.85%▼ 0.28 pp | 20.26%▼ 0.15 pp |
How to Read This Comparison
Valuation ratios (P/E, P/B) use the latest consolidated figures where available; growth numbers compare against the same period last year; shareholding percentages come from the most recent quarterly filings, with the change shown against the prior quarter. A "more favourable" highlight is relative between these two companies only — it is not a rating, a recommendation, or a comparison against the wider sector. Rows with no reported data for either company are hidden rather than shown empty.
Deep-dive each company on its stock page for quarterly results, technicals, filings and the full peer set: HEALTHCARE GLOB. ENT. and SHALBY.
Related Comparisons
Data source: NSE and company filings via StockeZee. This comparison is informational — it is not investment advice, and StockeZee is not a SEBI-registered investment adviser.